Drug Makers Seek Dismissal Of Wholesale Price Suit

Law360, New York (July 19, 2007, 12:00 AM EDT) -- Schering-Plough Corp. and its generic unit are aiming to throw out New York counties’ case in the massive antitrust class action against them and a slew of other pharmaceutical makers alleging they artificially inflated the prices for prescription drugs.

Schering-Plough and Warrick Pharmaceuticals Corp. called the amended complaint “woefully inadequate” on Wednesday and asked the U.S. District Court for the District of Massachusetts to dismiss the case in its entirety.

Echoing previous motions by fellow defendants, the two drug makers said the plaintiffs’ fraud claims should...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.